Skip to main content
. 2019 May 29;24(11):2052. doi: 10.3390/molecules24112052

Figure 4.

Figure 4

(A) a heterobivalent ligand, which is composed of two distinct pharmacophore groups (yellow and green beads) connected by a linker, targets both orthosteric and allosteric binding site simultaneously; (B) a homobivalent ligand, which consists of two identical pharmacophore groups (two yellow beads) linked by a proper linker, targets both allosteric and metastable binding sites simultaneously.